TMCnet - World's Largest Communications and Technology Community



Research and Markets: World Market for Pain Management Drugs and Devices to 2017
[June 26, 2014]

Research and Markets: World Market for Pain Management Drugs and Devices to 2017

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "The World Market for Pain Management Drugs and Devices" report to their offering.

The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to physicians and other clinicians has expanded. Solutions to pain disorders are still elusive but continued human and animal studies will help to further identify the biochemical and neurophysiological factors that influence pain.

The future of pain management will likely involve multidisciplinary departments dedicated to finding treatments that manage pain. The need is great worldwide for management of pain and there are still many facets of pain management that need to be explored.

Faced with intensifying competition and increasingly price sensitive markets, manufacturers in the area of pain management therapeutics are trying to differentiate their products to avoid price competition and to incease profits. However, there are a number of issues and trends that have a direct influence on this market and the manufacturer's ability to successfully operate in the market. A keen awareness of all facets of the industry including barriers will enable manufacturers to effectively challenge these issues and formulate plans to reduce or eliminate barriers in the treatment of pain.

The driving forces for this market include growth and aging of the global population, new products and technology, and increasing interest in multidisciplinary approaches to pain management.

The World Market for Pain Management Drugs and Devices, provides market estimates and forecasts for the following therapeutic categories:

  • Burn Pain
  • Cancer Pain
  • Dental/Facial Pain
  • Migraine Headache Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Obstetrical Pain
  • Pediatric Pain
  • Surgical and Trauma Pain

This report details the various categories of top prescription pain management drugs, describes U.S., European, Japanese and other markets in each of the specific pain areas. The report also covers drug delivery methods, pain management devices, and alternate treatment modalities that are influencing the market. It further identifies major market factors, which are discussed, and a total market summary is presented.

As part of the study the following competitors are profiled:

  • Abbott Laboratories
  • Actavis, Inc (formerly Watson Pharmaceuticals, Inc.)
  • AstraZeneca plc.
  • Baxter International, Inc.
  • BioDelivery Sciences International (BDSI)
  • Boehringer Ingelheim
  • Boston Scientific
  • Bristol-Myers Squibb Company
  • DepoMed
  • DURECT Corporation
  • Eli Lilly & Co.
  • Endo Health Solutions Inc
  • GlaxoSmithKline plc
  • Grunenthal Group
  • Medtronic, Inc.
  • Merck & Co.
  • Novartis
  • Pain Therapeutics, Inc
  • Pfizer, Inc
  • Purdue Pharma
  • QRx Pharma
  • Sanofi
  • St. Jude Medical, Inc
  • TEVA Pharmaceuticals Industries, Ltd
  • The Medicines Company
  • Valeant Pharmaceuticals International, Inc.
  • Zogenix, Inc.

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy